申请人:WARNER-LAMBERT COMPANY
公开号:EP0339600A2
公开(公告)日:1989-11-02
Use of compounds of the formula I
for the preparation of pharmaceuticals as analgesics or for the treatment of cerebrovascular or neurodegenerative disorders.
式 I 化合物的用途
用于制备
镇痛药或治疗脑血管疾病或神经退行性疾病的药物。